Provided by Tiger Fintech (Singapore) Pte. Ltd.

China SXT Pharmaceuticals

4.31
-1.2271-22.15%
Pre-market: 4.15-0.4100-8.99%07:46 EDT
Volume:117.64K
Turnover:567.86K
Market Cap:2.19M
PE:-0.15
High:5.50
Open:5.50
Low:4.27
Close:5.54
Loading ...

Company Profile

Company Name:
China SXT Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
75
Office Location:
178 North Taidong Road,Taizhou,Jiangsu Province,China
Zip Code:
225300
Fax:
- -
Introduction:
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.

Directors

Name
Position
Feng Zhou
Co-Chief Executive Officer, Director
Tong Liu
Independent Director
Xiaodong Ji
Independent Director
Yong Lip Chee
Independent Director
Jun Zheng
Director

Shareholders

Name
Position
Feng Zhou
Co-Chief Executive Officer, Director
Simon Lim Sze Beng
Co-Chief Executive Officer
Xiaodong Pan
Chief Financial Officer